NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
9.19
+0.01 (0.11%)
Nov 20, 2024, 4:00 PM EST - Market closed
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $274.30 million as of November 21, 2024. Its market cap has increased by 44.95% in one year.
Market Cap
274.30M
Enterprise Value
290.97M
1-Year Change
44.95%
Ranking
Category
Stock Price
$9.19
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has decreased from $393.28M to $274.30M, a decrease of -30.25%. That is a compound annual growth rate of -9.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 274.01M | 1.11% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nautilus Biotechnology | 281.26M |
| Accolade | 281.07M |
| Rezolute | 276.84M |
| Artiva Biotherapeutics | 274.47M |
| Mersana Therapeutics | 274.24M |
| AngioDynamics | 273.06M |
| Eton Pharmaceuticals | 271.28M |
| Poseida Therapeutics | 269.98M |